Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan

Atherosclerosis

Volumn 192, Issue 2, 2007, Pages 305-312

  Wang, Yuan Hung ^a   Wu, Meei Maan ^a   Hong, Chi Tzong ^a   Lien, Li Ming ^b   Hsieh, Yi Chen ^a   Tseng, Hung Pin ^c   Chang, Shu Feng ^d   Su, Che Long ^d   Chiou, Hung Yi ^a   Chen, Chien Jen ^e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c LOTUNG POH AI HOSPITAL   (Taiwan)

^d Division of Neurology   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Arsenic; Atherosclerosis; Glutathione S transferase; p53

Indexed keywords

ARGININE; ARSENIC; DRINKING WATER; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; ISOLEUCINE; PROLINE; PROTEIN P53; VALINE; WELL WATER;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EXPOSURE; FEMALE; GENDER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN VARIANT; SCORING SYSTEM; STENOSIS; TAIWAN;

AGE FACTORS; AGED; ARSENIC POISONING; CAROTID ARTERY DISEASES; COHORT STUDIES; FEMALE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK; SEX FACTORS; TAIWAN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34248156246     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.07.029     Document Type: Article

References (33)

1. Nordstrom D.K. Public health. Worldwide occurrences of arsenic in ground water. Science 296 (2002) 2143-2145
2. Campbell B.G. Broadsheet number 48: mercury, cadmium and arsenic: toxicology and laboratory investigation. Pathology 31 (1999) 17-22
3. Smith A.H., Lopipero P.A., Bates M.N., et al. Public health. Arsenic epidemiology and drinking water standards. Science 296 (2002) 2145-2146
4. Chen C.J., Wu M.M., Lee S.S., et al. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 8 (1988) 452-460
5. Yeh S., and How S.W. A pathological study on the blackfoot disease in Taiwan. Rep Inst Pathol Natl Taiwan Univ 14 (1963) 25-73
6. Hsueh Y.M., Wu W.L., Huang Y.L., et al. Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis 141 (1998) 249-257
7. Chen C.J., Chiou H.Y., Chiang M.H., et al. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol 16 (1996) 504-510
8. Chiou H.Y., Huang W.I., Su C.L., et al. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28 (1997) 1717-1723
9. Rahman M., Tondel M., Ahmad S.A., et al. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol 148 (1998) 198-203
10. Tseng C.H. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol Appl Pharmacol 197 (2004) 67-83
11. Chen C.J., Hsueh Y.M., Lai M.S., et al. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25 (1995) 53-60
12. Howard G., Sharrett A.R., Heiss G., et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC investigators. Stroke 24 (1993) 1297-1304
13. Salonen R., and Salonen J.T. Carotid atherosclerosis in relation to systolic and diastolic blood pressure: Kuopio Ischaemic heart disease risk factor study. Ann Med 23 (1991) 23-27
14. Geng Y.J. Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis. Curr Atheroscler Rep 3 (2001) 234-242
15. Geng Y.J. Regulation of programmed cell death or apoptosis in atherosclerosis. Heart Vessels Suppl. 12 (1997) 76-80
16. Hughes M.F. Arsenic toxicity and potential mechanisms of action. Toxicol Lett 133 (2002) 1-16
17. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 172 (2001) 249-261
18. Aposhian H.V., Zakharyan R.A., Avram M.D., et al. Oxidation and detoxification of trivalent arsenic species. Toxicol Appl Pharmacol 193 1 (2003) 1-8
19. Hayakawa T., Kobayashi Y., Cui X., et al. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch Toxicol 79 (2005) 183-191
20. Nesnow S., Roop B.C., Lambert G., et al. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem Res Toxicol 15 12 (2002) 1627-1634
21. Styblo M., Drobna Z., Jaspers I., et al. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect 110 Suppl. 5 (2002) 767-771
22. Strange R.C., Jones P.W., and Fryer A.A. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 112/113 (2000) 357-363
23. Strange R.C., Spiteri M.A., Ramachandran S., et al. Glutathione S-transferase family of enzymes. Mutat Res 482 (2001) 21-26
24. Tseng C.H., Huang Y.K., Huang Y.L., et al. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 206 (2005) 299-308
25. Wang C.H., Jeng J.S., Yip P.K., et al. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105 (2002) 1804-1809
26. Tseng C.H., Chong C.K., Chen C.J., et al. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 120 (1996) 125-133
27. Shantaram V. Pathogenesis of atherosclerosis in diabetes and hypertension. Clin Exp Hypertens 21 (1999) 69-77
28. Hessler J.R., Morel D.W., Lewis L.J., et al. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 3 (1983) 215-222
29. Pi J., Yamauchi H., Kumagai Y., et al. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ Health Perspect 110 (2002) 331-336
30. Tabas I. p53 and atherosclerosis. Circ Res 88 (2001) 747-749
31. Salazar A.M., Ostrosky-Wegman P., Menendez D., et al. Induction of p53 protein expression by sodium arsenite. Mutat Res 381 (1997) 259-265
32. Mass M.J., and Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 386 (1997) 263-277
33. Chiou H.Y., Hsueh Y.M., Hsieh L.L., et al. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res 386 (1997) 197-207